• Home
  • Contact Us
  • Try it!
  • Blog
  • Vizit Graphs

Follow us

Recent Posts

  • Biovista Harnesses New Kinds of Augmented and Artificial Intelligence to Address COVID-19 August 25, 2020
  • Repositioning Safety May 22, 2020
  • Artificial Intelligence firm Biovista repositions four promising therapeutics against COVID-19 April 22, 2020
  • Business Development Agent in Japan February 12, 2020
  • High Throughput Layout and Copy Paste July 5, 2019

Biovista Vizit

Biovista Vizit

  • Try it!
  • Blog
  • Vizit Graphs

Mechanistic analysis of Ivermectin

June 19, 2020COVID-19, Vizit Graphs
Mechanistic analysis of IvermectinEftychia Lekka2020-08-03T13:55:41+00:00
Mechanistic analysis of Ivermectin

Ivermectin is an anti-parasitic agent that has shown promise against the virus in vitro. Its potential mechanism of action (MoA) in COVID-19, is poorly understood.

Explore the live graph.

Tags: A.R.D.S., ABCB1, ACE, ACE2, ALANINE AMINOTRANSFERASE, ALBUMIN, ANTIBODY FORMATION, ASPARTATE AMINOTRANSFERASE, BREATH SHORTNESS, COUGH, CRP, DIARRHEA, DISTRESS RESPIRATORY, IL10, IL1B, IL6, IMMUNITY, IMMUNOCOMPROMISED HOST, INFECTION, INFLAMMATION, INJURY, INTERFERON, ITCH, IVERMECTIN, LDH, LIFE CYCLE STAGES, LUNG INFLAMMATION, MUSCLE STRAIN, MYALGIA, PAIN, RESPIRATION, RNA DEPENDENT RNA POLYMERASE, SARS-COV-2, SPIKE, TNF

Post navigation

← Mechanistic analysis of combination IFB-a2b chlorpheniramine, ibuprofen
Mechanistic analysis of Azithromycin →

Vizit Graphs Tag Cloud

COVID-19 IL10 RAS HELICOBACTER PYLORI ALZHEIMER'S DISEASE LISTERIA MONOCYTOGENES APOPTOTIC PROCESS IL2 SARS-COV-2 PD-1 MYALGIA IMMUNE RESPONSE ANGIOTENSIN II CANDIDA ALBICANS ESCHERICHIA COLI ACE2 ALBUMIN IMMUNITY CASP3 IL6 NFKB1 INTERFERON LACTATE DEHYDROGENASE COAGULATION TMPRSS2 PARKINSON DISEASE STAPHYLOCOCCUS AUREUS TNF NEUTROPHILS CD4 PSEUDOMONAS AERUGINOSA IL1B COGNITION CELL DIFFERENTIATION METFORMIN AUTOPHAGY INSULIN INFLAMMATION CELL PROLIFERATION IFNG RHEUMATOID ARTHRITIS CANCER AGING ACE INFLAMMATORY RESPONSE

© 2021 Biovista Vizit All Rights Reserved.